What do we know about the mechanism of action of disease-modifying treatments in MS?

被引：32

作者：

Hartung, HP ^{[1
]}

Bar-Or, A ^{[1
]}

Zoukos, Y ^{[1
]}

机构：

[1] Univ Dusseldorf, D-40225 Dusseldorf, Germany

来源：

关键词：

Public Health;

D O I：

10.1007/s00415-004-1504-y

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：12 / 12

页数：1

共 136 条

[1]

Ikuta undefined(1976)undefined Neurology 26 26-undefined

[2]

Dalton undefined(2004)undefined Brain 127 1101-undefined

[3]

Miller undefined(2003)undefined J Neurol 250 1407-undefined

[4]

Raine undefined(1984)undefined Lab Invest 50 608-undefined

[5]

Smith undefined(1992)undefined Prog Brain Res 94 411-undefined

[6]

Filippi undefined(2003)undefined Brain 126 433-undefined

[7]

Ferguson undefined(1997)undefined Brain 120 393-undefined

[8]

De Stefano undefined(2003)undefined Neurol Sci 24 S283-undefined

[9]

Grigoriadis undefined(2004)undefined Clin Neurol Neurosurg 106 211-undefined

[10]

Lee undefined(1999)undefined Brain 122 1261-undefined